A new COVID-19 variant officially designated as Lineage “P.3” was detected in the Philippines on 10 March 2021 as reported by the Philippine Genome Center (PGC). The variant was found from local samples in Central Visayas, collected on the same dates where there was a sharp increase in COVID-19 cases recorded in the region.


What do we know so far?

  • P.3 is designated as a variant under investigation (VUI) and not yet identified as a variant of concern (VOC) by the Department of Health (DOH), as the currently available data are not enough to conclude that it will have significant implications to public health. Public Health England has classified it as a VUI.
  • To date, there are 104 total infections caused by the P.3 variant in the Philippines, of which the majority are detected in Central Visayas. Samples from the Philippines were collected in late January up to February 2, 2021, and the sequencing run was conducted on February 4, 2021 by the PGC.
  • The results reported by PGC indicate that P.3 is found to bear multiple mutations of concern in the spike protein region. In simple terms, there were multiple changes detected in the spike region of the P.3 variant, the part of the virus responsible for attaching to human cells, which may possibly have “functional significance” as reported by PGC.
  • These mutations, or changes detected in P.3. are identified as E484K, N501Y, and P681H. They have been previously associated with known COVID-19 variants linked to possible increased transmissibility and immune escape. There is still no proof, based on available data, that P.3 is more infectious than the original version of Sars-CoV-2, but the presence of these three mutations suggests that it is possible. 
  • There are NO reports that the P.3 variant leads to worse symptoms of COVID-19.


What does it tell us?

  • Although not classified as a VOC, PGC recommends strengthening measures to prevent the spread of P.3 to other regions in the Philippines and other countries due to the potential public health implications of these mutations.
  • Regardless if we are situated in Metro Manila or in the provinces, we must not stop or even minimize practicing the minimum public health standards. With the recent announcement of Enhanced Community Quarantine in Metro Manila, Rizal, Laguna, Cavite, and Bulacan, the DOH urges the public to stay at home unless extremely necessary and remember to avoid the three Cs (Closed spaces, Crowded places, and Close contact settings). 


What is DOST-PCHRD doing?

  • DOST-PCHRD initiated the funding and support for the biosurveillance studies of PGC on COVID-19 in the Philippines through the ARCHER Program. This support started six months ago, in October 2020, to aid current government efforts to get a more comprehensive picture of the spread of the disease in the country. To date, the biosurveillance service of PGC is also being funded by the DOH.
  • DOST-PCHRD supports PGC’s recommendation to strengthen measures to prevent the spread of the P.3 variant to other regions and countries. So far, four, two, and one of each P.3 virus sequences have been submitted by the UK, Australia, Germany and Japan, respectively, in the Global Initiative on Sharing All Influenza Data (GISAID) database which has now more than 700,000 SARS-CoV-2 submitted sequences.
  • In the long term, the Council aims to aid the government in determining the dynamics of the spread of the disease throughout its course.
  • This health research effort aims to provide our policymakers guidance in future planning with regard to epidemics in the country. Collected data from this project will be part of a baseline for the country for improving our health disaster responses in the future.


Variants, strains, and mutations simplified

Although connected in several ways, the terms variants, strains, and mutations do not mean the same thing. In simple terms,

  • Even a virus commits errors in copying itself. When a virus makes copies of itself or duplicates inside our body, sometimes, there are letters in the genome that are not written correctly. As a result, there are copies that are not made exactly the same as the original version, and we call this mutation. Just like how mistakes are natural in people, mutations are also natural in viruses.
  • As a result of its error of not perfectly copying itself, this mutation changes the new copy’s genome. Take note that several mutations may exist in a single copy, and when this happens, a new variant of the virus occurs. 
  • strain, on the other hand, simply refers to a subtype of a larger virus species but has different characteristics. For example, SARS-CoV-2 is a strain of the larger coronavirus family that causes respiratory infections, in the same way, that MERS-CoV is also a strain of coronavirus.


With the upcoming Holy Week, everyone is encouraged to avoid large congregations and practice religious activities at home. It is always recommended to maintain social distance, wear masks when going outside, and wash hands frequently.

Source: https://www.pchrd.dost.gov.ph/news/6658-what-you-should-know-about-the-p-3-variant-detected-in-ph 

The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) recognizes the vital role of the research mentor who selflessly shares knowledge and skills, instills values and attitudes, and inspires those involved in the research process, thereby creating an enabling environment and contributing to capacity-building in research. 

The Best Mentor Award is offered biennially to recognize and reward mentors in health research who have built the capacities of researchers in the health sector and, in the process, propelled significant advances in the Philippine National Health Research System’s (PNHRS) thrusts as identified in the National Unified Health Research Agenda (NUHRA).

Awardees will be selected per cluster (Luzon, Visayas, Mindanao and NCR) and categorized according to their mentees (Undergraduate Students, Graduate Students and Junior/Early Career Researchers). Also, national winners will be chosen for each category who will be awarded during the PNHRS Week Celebration.

OBJECTIVE

Best Mentor Award recognizes excellence in mentorship that results in productivity of mentees in health research.

ELIGIBILITY

A. Who can nominate

The nominating party may be any of the following:

  • head of the nominee’s institution or immediate supervisor
  • colleague/s 
  • trainee/s 
  • student/advisee

Self-nomination is not allowed.

B. Who can be nominated

  1. must be a Filipino citizen
  2. must be with appropriate or relevant academic qualifications 
  3. must be actively involved in mentoring researchers/students or colleagues for at least 3 years 
  4. has a good track record as a researcher in terms of any of the following: publication, product development or policy formulation 
  5. professionally involved in health research activities either as a research program/project leader, principal and co-principal investigator, mentor/adviser/trainer, or author/co-author 
  6. actively involved in any health research activities in the last 5 years such as the conduct of research training and extension work, paper presentations, fund generation, research promotion and networking, research agenda setting, and capacity-building activities

*Winners are ineligible for subsequent nominations, while non-winners are still eligible for nominations if they submit a new set of documents but not for consecutive calls of nomination

HOW TO NOMINATE

Submit the recommendation form (either personally delivered, by courier, or thru email) for initial screening to the regional consortium secretariat. (Please refer to the attached list of regional consortia and contact information)

For completed DOST-PCHRD and ASTHRDP scholars, submit entries to DOST-PCHRD for screening and endorsement of the PCHRD Scholar’s Society (PSS).

A. For the qualified nominees

The requirements below should be submitted strictly within the deadline 

1. Five (5) hard copies of the following documents:

1.1. Accomplished curriculum vitae of the nominee using the prescribed format for Best Mentor Award  

1.2. A narrative description (1,000-1,500 words) of the nominee’s mentoring activities using the guide questions provided, accompanied by supporting documents, e.g.  photos and other relevant documentation. 

1.3. Description of other achievements attained related to health research for the last 5 years, including supporting documents e.g., photocopy of certificates of recognition/awards/honors received by the nominee, which are relevant to the nominee’s eligibility criteria in Section IV. B Who can be nominated.

2. Cite names of 5 mentees, their achievements in research, and a narrative description of the nominee’s contribution to the success of each mentored research. 

To be submitted in a folder with proper tabbing and table of contents. Supplemental documents and/or verifications may be required as deemed necessary. 

B. Selection Criteria

There will be a review of nominations by the Cluster/National Selection Committee based on the following criteria:

c.2.1.  Research Guidance                   44%

  • Quantitative Indicators – refer to the no. of research mentees guided, advised or mentored by the candidate; also includes the nominee’s years of experience in mentoring. 
  • Qualitative indicators – to be decided by the evaluators; may include extent, quality/result of the research guidance/mentoring done e.g., awards and other forms of recognition received by the mentor and/or other mentees

 

c.2.2.  Track Record in Research              21%              

  • Publications refer to peer-reviewed journals during the last 5 years: 

                 ○ main author in a Philippine journal or international journal
                 ○ co-author in a Philippine journal or international journal

  • Awards received refer to recognition received for the research completed as:

                 ○ main author/principal investigator in the Philippines or International 
                 ○ co-author/member of a research team in the Philippines or International

  • Paper presented refers to the number of times the nominee presented the research work/paper in conference, workshop by recognized organization (either oral or poster)
  • Completed research covers completed unpublished researches over the last 5 years 

 

c.2.3.   Dedication in promoting research     20%                                                                                 

  • Types of active involvement in five years

                   ○ Teacher, adviser, panel member, critic
                   ○ Advocate of health-related policies
                   ○ Reviewer of refereed journal article/editor/member of editorial board/team 
                   ○ Member of professional organization/network
                   ○ Trainor in training courses/resource person/lecturer
                   ○ Research manager/director, coordinator, evaluator

  • Quality of active involvement within 5 years as:

                   ○ Teacher, adviser, panel member, critic
                   ○ Advocate of health-related policies
                   ○ Reviewer of refereed journal articles, editor/member of editorial team
                   ○ Trainor in training courses/resource person
                   ○ Research manager, coordinator, evaluator

c.2.4. Contribution towards a supportive research environment      10%

  • Providing research opportunities as:

                   ○ Organizer/initiator of program, project, policy
                   ○ Organizer/initiator/member of team for workshops, conferences
                   ○ Organizer/initiator/member of team for training courses
                   ○ Director/chair/administrator for research
                   ○ Study group leader
                   ○ Research team leader

 c.2.5. Other Criteria as agreed by the Evaluators 5%   

This may include awards/recognition received by mentees/advisees/students of the nominee or any agreed criteria; impact of R&D in terms of patenting, commercialization, and/or utilization of research results into policies and actions such as training modules developed, teaching manuals, community modules, contribution to national health development/equity and/or relevance of research results in health care delivery; etc

 

ANNOUNCEMENT OF WINNERS AND PRIZES

  • All qualified nominees will receive certificates of recognition. 
  • Cluster Winners from Luzon, Visayas, Mindanao and National Capital Region will receive respective cash prizes and plaques of recognition. 

                   Mentors of Undergraduate Students -               P50,000.00
                   Mentors of Graduate Students -                        P50,000.00
                   Mentors of Junior/Early Career Researchers -  P100,000.00

 

  • National Winners for each category will receive respective additional cash prizes and trophies which will be awarded during the PNHRS Week Celebration.

                   Mentors of Undergraduate Students -               P150,000.00
                   Mentors of Graduate Students -                        P150,000.00 
                   Mentors of Junior/Early Career Researchers -  P200,000.00


TIMETABLE


Activity


2021 Timeline

Call for nomination

March – 1st week of May

Submission of recommendation form to the consortium

May 14, 2021

Submission of the endorsed recommendation forms to DOST-PCHRD

May 21, 2021

Submission of complete nominee’s documents to DOST-PCHRD

May – June 2021

Pre-screening of nominee’s complete documents

June

Selection Process

     -  Cluster

     -  National

June- July

Awarding of Winners

PNHRS Week

Celebration

(second week of August)

 

 

Source: https://www.pchrd.dost.gov.ph/news/6665-2021-call-for-nominations-for-best-mentor-in-health-research-award 

The Call for Proposals for the ASEAN-China Program on Public Health Emergency Preparedness Capacity (PROMPT) is now open!
This program is under the ASEAN-China Public Health Cooperation Initiative which focuses on enhancing regional preparedness capacity in response to the COVID-19 pandemic and future public health emergencies. To support this goal, the ASEAN-China PROMPT Program will carry out capacity-building activities, creation of information and data exchange, vaccine research and development, and provision of technical support to ASEAN institutions in public health emergency response.
The projects under the PROMPT Program shall support health policy objectives of ASEAN Member States and China, and contribute to closer inter-institutional connections and cooperation between ASEAN and China, which could be reflected by joint collaboration projects between health institutions and government agencies.
 
Projects under this Program shall also be able to deliver long-term and sustainable benefits based on explicit reference to design and implementation factors contributing to its sustainability.
 
Requirements:
  1. Government agencies or affiliated agencies, health or research institutions, universities from the ASEAN Member States may submit proposals. Partnerships between the ASEAN institutions and China are encouraged, during which a leading agency shall be identified as the project proponent and comply with the Rules of Procedure of Engagement of Entities with the ASEAN Health Sector if applicable.
  2. Proposals must use the template prescribed by the ASEAN Secretariat and go through ASEAN China Cooperation Fund (ACCF) project appraisal and approval process individually (templates may be downloaded here).
  3. For project proposals submitted with multi-year implementation of activities, it is recommended to have the initial activities be implemented within the first year, during which the outputs of initial activities will be evident and add value to the succeeding activities of the project proposal. 
  4. Budget of each project shall be evaluated based on the nature of the project and the project proposal on its own merit.
 
Any potential project proponent is advised to contact the focal points within the ASEAN  Secretariat and project officers of the ACCF Management Team before drafting and  submitting project proposals. Contact information is as follows: 
Project focal points:  
  1. Health Division from the ASEAN Secretariat, (This email address is being protected from spambots. You need JavaScript enabled to view it.)
  2. Mr. Gu Junjie, Programme Manager of the ACCF Management Team (This email address is being protected from spambots. You need JavaScript enabled to view it.) / (62)813-18628589  
 
Copy furnish to:
  1. Mr. Marco Antonio R. Bautista, DOST, This email address is being protected from spambots. You need JavaScript enabled to view it.
  2. Mr. Zymar P. Bandola, DOST, This email address is being protected from spambots. You need JavaScript enabled to view it.
  3. DFA-ASEAN, This email address is being protected from spambots. You need JavaScript enabled to view it.
  4. Philippine Mission to ASEAN, This email address is being protected from spambots. You need JavaScript enabled to view it.
This program is an open call and will be accepting proposals for projects with a duration between March 2021- February 2024. 
 
 

The Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD) together with the Department of Health (DOH) organized an online Good Clinical Practice (GCP) training program in preparation for the conduct of vaccine clinical trials.

The GCP training aims to capacitate community healthcare workers (CHWs) on upholding and safeguarding the rights of participants in vaccine clinical trials, and to provide a platform where the CHWs may raise their questions and concerns on the upcoming trial. 

Covering different areas that will help ensure the trial’s adherence to scientific and ethical standards, the training will feature modules from notable experts in the field:

1. DOST-PCHRD Executive Director Dr. Jaime C. Montoya - Clinical Trials Administrative Oversight 
2. Forum for Ethical Review Committees in Asia and the Western Pacific - Asian Regional Coordinator Dr. Cristina E. Torres - The Dos and Don'ts of Clinical Trials
3. University of the Philippines-Manila Research Ethics Board Coordinator Ms. Edlyn Jimenez - Informed Consent at Recruitment ng Participants
4. Philippine Clinical Research Professionals President Mr. Al Ryan Baniqued - Safety Reporting at Documentation ng Clinical Trials 

The training will follow a “flipped classroom” format, where the participants may access the modules at their own time and pace. Certificates will be provided for those who will complete the program.

Capacitating our community healthcare workers is very critical to ensure the success of vaccine clinical trials, especially since they will serve as the primary touchpoints of the participants,"  DOST-PCHRD Executive Director Jaime C. Montoya says. "It is our hope that through this program, we will be able to strengthen our efforts by making sure that we will always adhere to the highest scientific and ethical standards,” he adds.

All CHWs are welcome to join the online training, including City Health Workers, Municipal Health Workers, Barangay health workers, licensed doctors, nurses, midwives and pharmacists serving in public health centers and hospitals, and other licensed health professionals working in private clinics or hospitals.

Interested participants must take note of the following requirements for the online training:

1. Internet-enabled gadgets such as a laptop, mobile phone or tablet

2. Email account

3. Facebook account (optional)

Deadline of the registration for the online training is on April 12, 2021. Enrollment may be done through this link: bit.ly/GCPenrollment.

 

Source: https://www.pchrd.dost.gov.ph/news/6664-dost-pchrd-doh-organize-good-clinical-practice-gcp-training-program-in-preparation-for-vaccine-clinical-trials 

The DOST-PCHRD Undergraduate Thesis Grant in Natural Products provides fund support to all undergraduate students who will conduct their thesis on natural products. The program aims to sustain a research culture in natural products to increase the number of research and later on build a pool of researchers/experts specializing in the field. The program supports the Tuklas Lunas (Drug Discovery and Development) program of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) which aims to develop safe, effective, and affordable alternative drugs from the country’s natural resources.

Thesis grants will be given to two (2) undergraduate entries per region (subject to availability of funds). After completion of the project, a competition will be held for selected qualified students to recognize their innovative work on natural products.

Who can apply?

All undergraduate students of Pharmacy, Chemistry, Nursing, and Health and Allied Sciences who have thesis proposals on natural products may apply. The proposed thesis study must use plants indigenous in the region. The project must be completed a year after receiving the grant.

How to apply?

Applicants should submit the following documents to the Regional Health Research and Development Consortium (RHRDC):

  1. Duly accomplished prescribed research proposal form with college seal
  2. Endorsement letter from the institution signed by the head of the university and the college dean
  3. Soft copy of the proposal (word format)
  4. Hard copy of the proposal using A4 paper (3 copies)
  5. Certificate of plant authentication
  6. Appropriate clearances: 
    • Bureau of Animal Industry clearance for studies involving animal subjects
    • Biosafety Clearance for studies involving genetic engineering and pathogenic organisms
    • National Commission on Indigenous Peoples Clearance for studies involving Indigenous Peoples
    • Gratuitous Permit from Biodiversity Management Bureau for studies involving the collection of flora and fauna from DENR Protected Areas
    • Ethical clearance for studies involving human subjects
  7. Curriculum vitae of the students and adviser

Selection Criteria

The research proposals will be rated based on the following criteria:

  1. Technical merit
        • Objectives are specific, measurable, attainable, relevant, and time-bound
        • The study design supports the objectives
        • The study sample and methodology are appropriate
  2.  Data management
        • The plan for data collection is clearly described
        • Quality control procedures for data collection are in place
        • Statistical analysis is well described
  3.  Relevance/Significance
        • The study addresses an important health problem
        • The study contributes to the advancement of scientific knowledge
  4. Proponent/institution’s capacity
        • The investigators are qualified and appropriately trained to carry out the study
        • The proposed study is appropriate to the experience level of the investigators
        • The implementing/cooperating institution is capable of carrying out the proposed study

Thesis Grant 

  • Two (2) thesis proposals will be selected in each region. Researchers will receive a grant amounting to a maximum of Fifty Thousand Pesos (P 50,000.00).
  • The thesis grant will be deposited to the bank account of the thesis adviser and will be liquidated after the completion of the study
  • A Memorandum of Agreement will be signed between the students, adviser, head of the institution, and DOST-PCHRD
  • The grant must be expended as allocated in the approved line-item budget

Cash Award

Six (6) grantees will be selected as finalists to present their studies during the Philippine National Health Research System (PNHRS) week celebration. The top three (3) presentors will receive the following prizes:

Frist prize = P 30,000.00

P 20,000.00 for the student

 

P 10,000.00 for the adviser

Second prize = P 22,000.00

P 15,000.00 for the student

 

P 7,000.00 for the adviser

Third prize = P 15,000.00

P 10,000.00 for the student

 

P 5,000.00 for the adviser

Consolation prize

P 5,000 per group

Finalists will receive a plaque of recognition.

Schedule of Activities

ACTIVITY

DATE

Call for Applications

March to May 2021

Deadline of submission to the consortium

May 31, 2021

Endorsement of shortlisted entries to DOST-PCHRD

June 11, 2021

Evaluation of thesis proposals by the Selection Committee and Provision of grants to selected grantees

June to July 2021

Conduct of study

August 2021 to May 2022

Submission of completed studies to DOST-PCHRD

June 3, 2022

Selection of oral presentors by the Selection Committee

June to July 2022

Oral Presentation and Announcement of Winners

August 2022

For inquiries, please email This email address is being protected from spambots. You need JavaScript enabled to view it..

 

Source:https://www.pchrd.dost.gov.ph/news/6663-call-for-applications-2021-dost-pchrd-undergraduate-thesis-grant-in-natural-products 

Subcategories

Featured Links

PNHRS

http://www.healthresearch.ph

PCHRD

http://www.pchrd.dost.gov.ph

eHealth

http://www.ehealth.ph

Ethics

http://ethics.healthresearch.ph

ASEAN-NDI

http://www.asean-ndi.org

Events Calendar

April 2025
S M T W T F S
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3